SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

ABSTRACTWe studied plasma antibody responses of 35 patients about 1 month after SARS-CoV-2 infection. Titers of antibodies binding to the viral nucleocapsid and spike proteins were significantly higher in patients with severe disease. Likewise, mean antibody neutralization titers against SARS-CoV-2...

Full description

Bibliographic Details
Main Authors: Pengfei Wang, Lihong Liu, Manoj S. Nair, Michael T. Yin, Yang Luo, Qian Wang, Ting Yuan, Kanako Mori, Axel Guzman Solis, Masahiro Yamashita, Ankur Garg, Lawrence J. Purpura, Justin C. Laracy, Jian Yu, Leemor Joshua-Tor, Joseph Sodroski, Yaoxing Huang, David D. Ho
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
SARS-CoV-2
antibody
neutralization
severe
non-severe
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1823890

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2020.1823890

Similar Items